Bausch Health Companies Inc (BHC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Bausch Health Companies Inc (BHC) has a cash flow conversion efficiency ratio of 1.139x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$405.00 Million ≈ $292.97 Million USD) by net assets (CA$355.65 Million ≈ $257.27 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Bausch Health Companies Inc - Cash Flow Conversion Efficiency Trend (1993–2024)
This chart illustrates how Bausch Health Companies Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read BHC total liabilities for a breakdown of total debt and financial obligations.
Bausch Health Companies Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bausch Health Companies Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Nanjing Sunlord Electronics Corporation LTD
SHE:300975
|
-0.001x |
|
HeiLongJiang Kingland Technology Co Ltd
SHE:000711
|
-0.015x |
|
Monadelphous Group Ltd
AU:MND
|
0.312x |
|
Henan Hanwei Electronics Co
SHE:300007
|
-0.020x |
|
DCM Shriram Limited
NSE:DCMSHRIRAM
|
0.210x |
|
OCADO GROUP SP.ADR 1/2
F:0OC1
|
N/A |
|
Hunan Boyun New Materials Co Ltd
SHE:002297
|
0.037x |
|
Ascletis Pharma Inc
F:2VJ
|
-0.018x |
Annual Cash Flow Conversion Efficiency for Bausch Health Companies Inc (1993–2024)
The table below shows the annual cash flow conversion efficiency of Bausch Health Companies Inc from 1993 to 2024. For the full company profile with market capitalisation and key ratios, see Bausch Health Companies Inc stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CA$-322.00 Million ≈ $-232.93 Million |
CA$1.60 Billion ≈ $1.16 Billion |
-4.960x | +60.59% |
| 2023-12-31 | CA$-82.00 Million ≈ $-59.32 Million |
CA$1.03 Billion ≈ $746.53 Million |
-12.585x | -349.48% |
| 2022-12-31 | CA$260.00 Million ≈ $188.08 Million |
CA$-728.00 Million ≈ $-526.62 Million |
-2.800x | +93.32% |
| 2021-12-31 | CA$-34.00 Million ≈ $-24.60 Million |
CA$1.43 Billion ≈ $1.03 Billion |
-41.941x | -2383.93% |
| 2020-12-31 | CA$605.00 Million ≈ $437.65 Million |
CA$1.11 Billion ≈ $803.68 Million |
1.836x | +38.98% |
| 2019-12-31 | CA$1.14 Billion ≈ $821.77 Million |
CA$1.50 Billion ≈ $1.09 Billion |
1.321x | +147.80% |
| 2018-12-31 | CA$2.81 Billion ≈ $2.04 Billion |
CA$1.50 Billion ≈ $1.09 Billion |
0.533x | +38.40% |
| 2017-12-31 | CA$5.94 Billion ≈ $4.30 Billion |
CA$2.29 Billion ≈ $1.66 Billion |
0.385x | -39.86% |
| 2016-12-31 | CA$3.26 Billion ≈ $2.36 Billion |
CA$2.09 Billion ≈ $1.51 Billion |
0.641x | +75.54% |
| 2015-12-31 | CA$6.03 Billion ≈ $4.36 Billion |
CA$2.20 Billion ≈ $1.59 Billion |
0.365x | -13.58% |
| 2014-12-31 | CA$5.43 Billion ≈ $3.93 Billion |
CA$2.29 Billion ≈ $1.66 Billion |
0.422x | +112.08% |
| 2013-12-31 | CA$5.23 Billion ≈ $3.79 Billion |
CA$1.04 Billion ≈ $753.74 Million |
0.199x | +12.73% |
| 2012-12-31 | CA$3.72 Billion ≈ $2.69 Billion |
CA$656.58 Million ≈ $474.96 Million |
0.177x | +4.62% |
| 2011-12-31 | CA$4.01 Billion ≈ $2.90 Billion |
CA$676.47 Million ≈ $489.35 Million |
0.169x | +215.02% |
| 2010-12-31 | CA$4.91 Billion ≈ $3.55 Billion |
CA$263.19 Million ≈ $190.39 Million |
0.054x | -79.89% |
| 2009-12-31 | CA$1.35 Billion ≈ $979.73 Million |
CA$360.90 Million ≈ $261.07 Million |
0.266x | +56.71% |
| 2008-12-31 | CA$1.20 Billion ≈ $869.22 Million |
CA$204.32 Million ≈ $147.81 Million |
0.170x | -35.25% |
| 2007-12-31 | CA$1.30 Billion ≈ $938.82 Million |
CA$340.85 Million ≈ $246.57 Million |
0.263x | -35.35% |
| 2006-12-31 | CA$1.28 Billion ≈ $929.45 Million |
CA$521.93 Million ≈ $377.56 Million |
0.406x | +12.50% |
| 2005-12-31 | CA$1.38 Billion ≈ $997.94 Million |
CA$498.11 Million ≈ $360.32 Million |
0.361x | +77.00% |
| 2004-12-31 | CA$1.36 Billion ≈ $982.59 Million |
CA$277.09 Million ≈ $200.44 Million |
0.204x | -36.22% |
| 2003-12-31 | CA$881.60 Million ≈ $637.73 Million |
CA$281.98 Million ≈ $203.98 Million |
0.320x | -19.04% |
| 2002-12-31 | CA$845.69 Million ≈ $611.76 Million |
CA$334.10 Million ≈ $241.69 Million |
0.395x | +56.58% |
| 2001-12-31 | CA$1.13 Billion ≈ $814.58 Million |
CA$284.12 Million ≈ $205.53 Million |
0.252x | -41.54% |
| 2000-12-31 | CA$237.46 Million ≈ $171.77 Million |
CA$102.49 Million ≈ $74.14 Million |
0.432x | +131.96% |
| 1999-12-31 | CA$435.30 Million ≈ $314.89 Million |
CA$81.00 Million ≈ $58.59 Million |
0.186x | -82.23% |
| 1998-12-31 | CA$51.20 Million ≈ $37.04 Million |
CA$53.60 Million ≈ $38.77 Million |
1.047x | +1738.12% |
| 1997-12-31 | CA$75.50 Million ≈ $54.62 Million |
CA$4.30 Million ≈ $3.11 Million |
0.057x | +137.53% |
| 1996-12-31 | CA$36.90 Million ≈ $26.69 Million |
CA$-5.60 Million ≈ $-4.05 Million |
-0.152x | -107.12% |
| 1995-12-31 | CA$14.60 Million ≈ $10.56 Million |
CA$31.10 Million ≈ $22.50 Million |
2.130x | +530.85% |
| 1994-12-31 | CA$7.70 Million ≈ $5.57 Million |
CA$2.60 Million ≈ $1.88 Million |
0.338x | -58.19% |
| 1993-12-31 | CA$-2.60 Million ≈ $-1.88 Million |
CA$-2.10 Million ≈ $-1.52 Million |
0.808x | -- |
About Bausch Health Companies Inc
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally. The company operates throu… Read more